This demonstrates that decreased IGFBP-1 in obese/overweight children is simply not a consequence of increased fatness/adiposity, but it may reflect other independent metabolic processes conveying higher risk for dyslipidemia and type 2 diabetes. Here, IGFBP1 is linked to metabolic syndrome.